Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

What is known and objective: We report a special case of fenofibrate-induced acute severe DILI with sudden onset and rapid recovery, which is different from those in the LiverTox database. Case summary description: The acute severe DILI occurred within only 4 days after fenofibrate initial treatment for hypertriglyceridemia. Liver enzyme levels eventually declined to normal within two weeks after the discontinuation of fenofibrate. What is new and Conclusion: Early detection of elevated hepatic enzymes after fenofibrate initial treatment helps physicians to avoid delayed diagnosis and subsequent treatment.

Cite

CITATION STYLE

APA

Ma, S., Liu, S., Wang, Q., Chen, L., Yang, P., & Sun, H. (2020). Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database. Journal of Clinical Pharmacy and Therapeutics, 45(1), 204–207. https://doi.org/10.1111/jcpt.13042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free